The U.S. Food and Drug Administration has approved the breakthrough drug Keytruda to treat advanced non-small cell lung cancer, signaling a paradigm shift in the way the deadliest of all cancers is treated.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1LqdIqo
No comments:
Post a Comment